Ion Agirrezabal

405 total citations
24 papers, 288 citations indexed

About

Ion Agirrezabal is a scholar working on Hepatology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Ion Agirrezabal has authored 24 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Ion Agirrezabal's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Advanced Radiotherapy Techniques (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Ion Agirrezabal is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Advanced Radiotherapy Techniques (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Ion Agirrezabal collaborates with scholars based in United Kingdom, Spain and United States. Ion Agirrezabal's co-authors include Pablo Villoslada, Sergio Ardanza-Trevijano, Nieves Vélez de Mendizábal, Francisco J. Esteban, Joaquín Goñi, Jorge Sepulcre, Xavier Montalbán, Albert Saiz, Victoria K. Brennan and Manuel Comabella and has published in prestigious journals such as Diabetes Care, European Journal of Cancer and Bone.

In The Last Decade

Ion Agirrezabal

21 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ion Agirrezabal United Kingdom 8 124 74 40 39 36 24 288
Ellen Q. Wang United States 9 97 0.8× 18 0.2× 23 0.6× 53 1.4× 37 1.0× 17 403
Clive Kind United Kingdom 9 153 1.2× 58 0.8× 7 0.2× 8 0.2× 38 1.1× 14 322
Mario Boehm Germany 11 180 1.5× 21 0.3× 16 0.4× 8 0.2× 42 1.2× 19 496
Shengkun Peng China 8 119 1.0× 22 0.3× 24 0.6× 10 0.3× 110 3.1× 18 359
Sandesh Chopade United Kingdom 5 155 1.3× 22 0.3× 5 0.1× 19 0.5× 25 0.7× 10 416
Junming Xu China 12 239 1.9× 20 0.3× 20 0.5× 18 0.5× 97 2.7× 27 402
Qian Jiang China 10 77 0.6× 37 0.5× 7 0.2× 20 0.5× 81 2.3× 22 346
Anees M. Dauki United States 8 99 0.8× 15 0.2× 22 0.6× 5 0.1× 53 1.5× 15 258
Elisabeth del Río Spain 14 267 2.2× 86 1.2× 19 0.5× 71 1.8× 221 6.1× 24 633

Countries citing papers authored by Ion Agirrezabal

Since Specialization
Citations

This map shows the geographic impact of Ion Agirrezabal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ion Agirrezabal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ion Agirrezabal more than expected).

Fields of papers citing papers by Ion Agirrezabal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ion Agirrezabal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ion Agirrezabal. The network helps show where Ion Agirrezabal may publish in the future.

Co-authorship network of co-authors of Ion Agirrezabal

This figure shows the co-authorship network connecting the top 25 collaborators of Ion Agirrezabal. A scholar is included among the top collaborators of Ion Agirrezabal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ion Agirrezabal. Ion Agirrezabal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matilla, Ana, Marı́a Varela, Mercedes Iñarrairaegui, et al.. (2025). Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial. Journal of Patient-Reported Outcomes. 9(1). 39–39.
2.
Jesus, Victor Hugo Fonseca de, et al.. (2024). Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis. Advances in Therapy. 41(4). 1606–1620. 1 indexed citations
3.
Agirrezabal, Ion, Richard F. Pollock, Victoria K. Brennan, et al.. (2024). Association of adverse events and quality of life in patients with unresectable hepatocellular carcinoma. Quality of Life Research. 33(12). 3377–3386.
4.
Agirrezabal, Ion, et al.. (2024). An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom. Clinical Drug Investigation. 44(6). 399–412. 2 indexed citations
5.
Agirrezabal, Ion, Mohamed Bouattour, David J. Pinato, et al.. (2023). Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison. European Journal of Cancer. 196. 113427–113427. 8 indexed citations
6.
7.
8.
9.
Lo, Siu Hing, Rohini Sharma, Charlotte Costentin, et al.. (2021). Patient Preferences for Advanced Hepatocellular Carcinoma Treatment: A Multicountry Stated Preference Study. Future Oncology. 17(32). 4275–4287. 16 indexed citations
10.
11.
Agirrezabal, Ion, Roman Hájek, Jiří Minařík, et al.. (2019). Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data. The European Journal of Health Economics. 21(2). 219–233. 5 indexed citations
12.
Agirrezabal, Ion, et al.. (2019). PBI35 HEALTH ECONOMICS MODELLING FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMP): A TARGETED LITERATURE REVIEW (LR). Value in Health. 22. S423–S423. 1 indexed citations
13.
Agirrezabal, Ion, Juan Manuel Cabasés Hita, Gian Luca Di Tanna, & Eduardo Sánchez. (2019). Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018. Bone. 130. 115125–115125. 8 indexed citations
14.
15.
Agirrezabal, Ion, et al.. (2017). STATUS OF DISINVESTMENT INITIATIVES IN LATIN AMERICA: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW AND A QUESTIONNAIRE. International Journal of Technology Assessment in Health Care. 33(6). 674–680. 6 indexed citations
16.
Graham, James E., Doreen McBride, Donald E. Stull, et al.. (2016). Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria. PharmacoEconomics. 34(8). 815–827. 25 indexed citations
17.
Graham, James E., et al.. (2015). Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu). Value in Health. 18(7). A423–A423. 1 indexed citations
18.
19.
Agirrezabal, Ion, et al.. (2014). Analysing The Effects of a Disinvestment Decision in Breast Cancer Screening Programmes in Asia-Pacific Countries: A Modelling Approach. Value in Health. 17(7). A735–A735. 1 indexed citations
20.
Goñi, Joaquín, Francisco J. Esteban, Nieves Vélez de Mendizábal, et al.. (2008). A computational analysis of protein-protein interaction networks in neurodegenerative diseases. BMC Systems Biology. 2(1). 52–52. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen Q. Wang Breakdown of academic impact, for papers by Clive Kind Breakdown of academic impact, for papers by Mario Boehm Breakdown of academic impact, for papers by Shengkun Peng Breakdown of academic impact, for papers by Sandesh Chopade Breakdown of academic impact, for papers by Junming Xu Breakdown of academic impact, for papers by Qian Jiang Breakdown of academic impact, for papers by Anees M. Dauki Breakdown of academic impact, for papers by Elisabeth del Río
Rankless by CCL
2026